Review
Aug 2026
Candidate Residual Inflammatory Risk in HFpEF: A Multiorgan Framework for Longitudinal Phenotyping, Trial Enrichment, and Therapeutic Evidence Appraisal.
Zhao-Qi Yan, Xiang-Yi Pu, Tiantian Ren et al.
· Cardiovascular Drugs and The... · 0 citations